Cited by 327Alzheimer's disease research and treatmentsUbiquitin and proteasome pathwaysHeat shock proteins research

Proteasomal degradation of tau protein

Open access
David, Della C., Layfield, Robert, Serpell, Louise, Narain, Yolanda, Goedert, Michel, Spillantini, Maria Grazia·2002·Journal of Neurochemistry

Abstract

Filamentous inclusions composed of the microtubule-associated protein tau are a defining characteristic of a large number of neurodegenerative diseases. Here we show that tau degradation in stably transfected and non-transfected SH-SY5Y cells is blocked by the irreversible proteasome inhibitor lactacystin. Further, we find that in vitro, natively unfolded tau can be directly processed by the 20S proteasome without a requirement for ubiquitylation, and that a highly reproducible pattern of degradation intermediates is readily detectable during this process. Analysis of these intermediates shows that 20S proteasomal processing of tau is bi-directional, proceeding from both N- and C-termini, and that populations of relatively stable intermediates arise probably because of less efficient digestion of the C-terminal repeat region. Our results are consistent with an in vivo role for the proteasome in tau degradation and support the existence of ubiquitin-independent pathways for the proteasomal degradation of unfolded proteins.

Integrity signals

Registry

Crossref · 10.1046/j.1471-4159.2002.01137.x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 57 · Cited by 327

Authors
David, D. C., Layfield, R., Serpell, L., Narain, Y., Goedert, M., & Spillantini, M. G.
Affiliations
  • University of Cambridge (GB)
  • MRC Laboratory of Molecular Biology (GB)
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2002-09-18
Volume
83
Issue
1
Pages
176-185
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1544371346
Cited by
327
References
57
Citations by year
2026: 5 · 2025: 10 · 2024: 7 · 2023: 11 · 2022: 9 · 2021: 15 · 2020: 11 · 2019: 17 · 2018: 16 · 2017: 17 · 2016: 10 · 2015: 14 · 2014: 12 · 2013: 14 · 2012: 19
FWCI
9.41
Type
journal article
Language
en
Open access
Locations
  • Journal of Neurochemistry (publishedVersion)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Keywords
tau protein, proteasomal degradation, 20S proteasome, lactacystin, ubiquitin-independent degradation, intrinsically disordered proteins, degradation intermediates, neurodegenerative diseases, SH-SY5Y cells, microtubule-associated proteins
MeSH terms
Acetylcysteine, Cysteine Endopeptidases, Humans, Multienzyme Complexes, Neuroblastoma, Transfection, Tumor Cells, Cultured, Blotting, Western, Cysteine Proteinase Inhibitors, tau Proteins, Protein Folding, Protein Isoforms, Ubiquitin, Proteasome Endopeptidase Complex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review